Committed Investment: September, 2021
Status: Active Portfolio Company
Immuto Scientific (Madison) is a biotechnology company dedicated to developing breakthrough solutions that advances drug discovery to treat difficult-to-cure diseases such as cancer. Immuto’s patented technology was developed through a collaboration between the UW-Madison labs in the Electrical Engineering and Biochemistry Departments. Immuto has spun-out of UW-Madison, raised a $2.3 million seed round that closed in September 2021, and now has a commercial lab that is open for business. The company has already begun working on customer projects, and its focus is on becoming a premier contract research organization that provides customers with a best-in-class service using its proprietary technology.
